Medical Device News Magazine

New ECTR Blade Assembly from Hand Biomechanics Lab Could Save up to $10,000 Per Surgeon/Per Year

Hand Biomechanics Lab Returns to the ECTR Market

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Hand Biomechanics Lab returns to the ECTR market with a new, drop-in replacement Disposable Blade Assembly for use with the 3M™ Agee Inside Job or MicroAire SmartRelease® systems. The device is a transparent swap for the popular pistol grip system that was developed by HBL founder, Dr. John Agee. Through a collaboration with the orthopedic division of 3M, Dr. Agee and 3M were first to market under patent in 1990.

“We were first to develop and market this system, now we’re first to reduce the cost,” states Dustin Dequine, CFO of HBL. The New ECTR Blade Assembly works with the MicroAire or 3M systems available at many hospitals and surgery centers nationwide. “Our goal is to bring cost savings to this segment as we continue to work to improve patient outcomes,” said Mr. Dequine.

HBL sells the ECTR Disposable Blade Assembly as a 6 pack for $545. The current standard device sold in a 6 pack is priced around $1,140 according to the public, published pricing charged to the Veteran’s Administration. In other words, the HBL Blade Assembly will sell for about half of the current standard pricing. A typical surgeon performs 100 ECTR procedures annually, so HBL’s new device could save the facility as much as $10,000 per year.

Christopher Wilson, MD of Hand Surgery Associates in Sacramento CA, performed a cadaver session with the new device and states, “The HBL Blade Assembly is essentially the same as the current device, but at a substantially lower cost, so it just makes sense.”

Despite the lower cost, the new device is nothing short of the highest quality. The probe itself is injection molded from a medical grade high-performance semi-crystalline thermoplastic. Compared with the current “standard”, the new device offers increased stiffness for improved tactile feel and a wider viewing area with less instrumentation in the field of view for improved visibility of soft tissues.

HBL has designed and patented unique medical devices that have been sold in the US for more than 30 years, and continues to work toward the development of new products for the benefit of patient care.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”